Discharge Hospice Referral and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries Hospitalized for Heart Failure
暂无分享,去创建一个
M. Rich | C. Morgan | R. Allman | J. Roseman | W. Aronow | G. Fonarow | M. Zile | Cynthia J Brown | R. Kheirbek | M. Blackman | M. Bakitas | Steven N. Singh | R. Fletcher | Kanan Patel | T. Love | Cynthia J. Brown | Ali Ahmed | F. A. Bailey | D. Bearden | Rodney O. Tucker | Sridivya Parvataneni | M. Ahmed | A. Ahmed | R. Fletcher
[1] C. Morgan,et al. Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure. , 2015, The American journal of medicine.
[2] Maureen A. Smith,et al. Hospice Enrollment, Local Hospice Utilization Patterns, and Rehospitalization in Medicare Patients. , 2015, Journal of palliative medicine.
[3] J. Butler,et al. Advance directives among hospitalized patients with heart failure. , 2015, JACC. Heart failure.
[4] GozaloPedro,et al. A National Study of Live Discharges from Hospice , 2014 .
[5] R. Gramling,et al. Palliative care referral among patients hospitalized with advanced heart failure. , 2014, Journal of palliative medicine.
[6] C. Morgan,et al. Lack of Association Between Spironolactone Use and 30-Day All-Cause Readmission In Hospitalized Medicare Beneficiaries With Systolic Heart Failure Eligible for Spironolactone Therapy , 2014 .
[7] K. Lohr,et al. Transitional Care Interventions to Prevent Readmissions for Persons With Heart Failure , 2014, Annals of Internal Medicine.
[8] C. Morgan,et al. DISCHARGE INITIATION OF ACE INHIBITORS OR ARBS IS ASSOCIATED WITH SIGNIFICANTLY LOWER 30-DAY ALL-CAUSE READMISSION IN HOSPITALIZED OLDER PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION , 2014 .
[9] J. Fleg,et al. Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failure. , 2014, The American journal of medicine.
[10] J. Fleg,et al. Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure. , 2014, The American journal of medicine.
[11] J. Fleg,et al. Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure. , 2013, The American journal of medicine.
[12] R. Kheirbek,et al. Trajectory of illness for patients with congestive heart failure. , 2013, Journal of palliative medicine.
[13] M. Gheorghiade,et al. Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fraction. , 2013, The American journal of medicine.
[14] M. Konstam. Heart failure in the lifetime of Musca domestica (the common housefly). , 2013, JACC. Heart failure.
[15] Jeremiah R. Brown,et al. Palliative care consultations for heart failure patients: how many, when, and why? , 2013, Journal of cardiac failure.
[16] M. Rich,et al. Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease. , 2013, The American journal of medicine.
[17] R. Allman,et al. Baseline characteristics, quality of care, and outcomes of younger and older Medicare beneficiaries hospitalized with heart failure: findings from the Alabama Heart Failure Project. , 2012, International journal of cardiology.
[18] S. Enguídanos,et al. 30-day readmissions among seriously ill older adults. , 2012, Journal of palliative medicine.
[19] M. Rich,et al. Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease. , 2012, The American journal of medicine.
[20] K. Schulman,et al. Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007. , 2011, Archives of internal medicine.
[21] Roger B. Davis,et al. Association of hospice agency profit status with patient diagnosis, location of care, and length of stay. , 2011, JAMA.
[22] J. Rassen,et al. The comparative safety of analgesics in older adults with arthritis. , 2010, Archives of internal medicine.
[23] Nancy M Albert,et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. , 2010, Journal of cardiac failure.
[24] R. McKelvie,et al. Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) Trial , 2010, Circulation.
[25] P. Brubaker,et al. Circ Heart Fail , 2010 .
[26] D. Meier,et al. Palliative Care in the Treatment of Advanced Heart Failure , 2009, Circulation.
[27] Sarah J. Goodlin,et al. Palliative care in congestive heart failure. , 2009, Journal of the American College of Cardiology.
[28] Richard E. Rohr,et al. Rehospitalizations among patients in the Medicare fee-for-service program. , 2009, The New England journal of medicine.
[29] Mark V. Williams,et al. Rehospitalizations among patients in the Medicare fee-for-service program. , 2009, The New England journal of medicine.
[30] W. Peacock,et al. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis , 2008, Emergency Medicine Journal.
[31] S. Payne,et al. Predicting mortality among a general practice-based sample of older people with heart failure , 2008, Chronic illness.
[32] Nancy M Albert,et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. , 2007, Journal of the American College of Cardiology.
[33] M. Gheorghiade,et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. , 2006, European heart journal.
[34] M. Rich,et al. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. , 2006, European heart journal.
[35] D. Rubin. Using Propensity Scores to Help Design Observational Studies: Application to the Tobacco Litigation , 2001, Health Services and Outcomes Research Methodology.
[36] R. Califf,et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. , 2002, JAMA.
[37] Paul R. Rosenbaum,et al. Sensitivity to Hidden Bias , 2002 .
[38] Roger B. Davis,et al. The Last Six Months of Life for Patients with Congestive Heart Failure , 2000, Journal of the American Geriatrics Society.
[39] D. DeMets,et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. , 1991, The New England journal of medicine.
[40] D. Rubin,et al. The central role of the propensity score in observational studies for causal effects , 1983 .